Intragastric Balloons Market to Reach USD 364.6 Million by 2036, Driven by Rising Obesity Prevalence and Minimally Invasive Weight-loss Treatments

The global intragastric balloons market is witnessing strong expansion as obesity rates continue to rise and patients increasingly seek minimally invasive alternatives to conventional bariatric surgery. According to the latest industry analysis, the global intragastric balloons market was valued at USD 86.8 million in 2025 and is projected to reach USD 364.6 million by 2036, expanding at a CAGR of 13.9% from 2026 to 2036.

The market is primarily driven by the increasing global prevalence of obesity and overweight, growing awareness of non-surgical weight-loss procedures, and technological advancements in swallowable and adjustable balloon systems. Intragastric balloons temporarily occupy space in the stomach, helping patients feel full sooner and potentially reduce food intake as part of a medically supervised weight-management program.

Growing demand for reversible and less invasive obesity interventions is creating opportunities across hospitals, ambulatory surgical centers, gastroenterology practices, and specialty obesity clinics. Advances in balloon materials, placement techniques, adjustability, and patient monitoring are further supporting market development.

→Discover Market Opportunities - Request Your Sample Copy Now: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=26006

Rising Global Prevalence of Obesity Drives Market Growth

The increasing prevalence of obesity and overweight is one of the strongest factors supporting the growth of the global intragastric balloons market.

Obesity has become a major public health concern as sedentary lifestyles, urbanization, dietary changes, and increased consumption of calorie-dense processed foods contribute to rising body weight across populations. Excess weight is associated with several chronic conditions, including type 2 diabetes, cardiovascular disease, hypertension, and sleep apnea.

This growing disease burden is increasing demand for effective weight-management interventions. While lifestyle modification remains an important component of obesity management, some patients seek additional medical interventions when diet and exercise alone do not provide sufficient weight reduction.

Intragastric balloons offer a temporary and minimally invasive approach that can complement dietary counseling and behavioral modification. By occupying volume within the stomach, the balloon can promote earlier feelings of satiety and help support reduced food consumption.

Increasing awareness among patients and healthcare professionals regarding endoscopic weight-loss therapies is therefore contributing to greater acceptance of intragastric balloon procedures.

Growing Demand for Minimally Invasive Weight-loss Procedures

The shift toward minimally invasive healthcare procedures is another important driver of the intragastric balloons market.

Traditional bariatric surgery can involve significant procedural complexity, hospitalization, and recovery requirements. Intragastric balloon therapy provides an alternative for eligible patients who prefer a less invasive approach.

Most conventional balloon systems are introduced through the mouth and positioned in the stomach, avoiding external surgical incisions. Depending on the specific technology, balloon placement and removal may involve endoscopic procedures and clinical supervision.

The temporary nature of the treatment is also attractive to some patients. Unlike permanent surgical alterations to the digestive system, intragastric balloons are designed to remain in place for a defined period before being removed or naturally passed, depending on the product.

As patients become increasingly informed about available obesity treatments, demand is shifting toward personalized interventions that balance effectiveness, invasiveness, recovery requirements, and treatment duration.

Technological Advancements in Swallowable and Adjustable Balloons

Innovation in swallowable, adjustable, and next-generation intragastric balloon systems is expected to significantly influence market expansion.

Swallowable balloons are designed to simplify the treatment process by reducing or eliminating some of the procedural requirements associated with conventional endoscopic placement. This can potentially improve accessibility and convenience for appropriately selected patients.

Adjustable balloon systems represent another important area of technological development. These systems allow physicians to modify balloon volume during treatment according to patient response and tolerance. This personalization can help healthcare professionals manage treatment more flexibly.

Manufacturers are also working on improved balloon materials, valve systems, durability, and deflation mechanisms. Such innovations are intended to enhance patient comfort and reduce complications associated with balloon migration, deflation, or removal.

The integration of digital health technologies and remote patient monitoring into obesity-management programs could further enhance follow-up care. Patients can receive nutritional guidance, behavioral support, and ongoing monitoring alongside balloon therapy.

As clinical evidence and physician familiarity with newer technologies increase, technological innovation is expected to remain a major factor shaping the competitive landscape.

Rising Medical Tourism Creates New Market Opportunities

The expansion of medical tourism for affordable obesity treatment presents a significant opportunity for intragastric balloon manufacturers and healthcare providers.

Countries such as India, Thailand, Turkey, Mexico, and the United Arab Emirates have developed medical tourism ecosystems that attract international patients seeking specialized healthcare services at comparatively lower costs.

Intragastric balloon procedures can be attractive to medical tourists because they are generally less invasive than major bariatric operations and may involve relatively short clinical stays, depending on the treatment system and patient requirements.

Healthcare providers increasingly offer comprehensive obesity-management packages that can include medical consultation, diagnostic assessments, balloon placement, nutritional counseling, accommodation, and follow-up services.

The development of internationally accredited hospitals, specialized bariatric centers, experienced gastroenterologists, and modern endoscopy infrastructure is further strengthening the appeal of medical tourism.

However, international treatment also requires appropriate patient selection, continuity of medical care, and follow-up arrangements. Healthcare providers and manufacturers that establish reliable post-treatment support networks could gain a competitive advantage in this emerging market.

→Explore Strategies & Trends - Request Full Report Access – https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=26006

Single Balloon Segment Dominates the Market

Based on product type, the single balloon segment accounted for approximately 54.2% of global intragastric balloons market revenue in 2025, making it the leading product category.

Single-balloon systems have gained broad acceptance because of their established clinical use, relatively straightforward placement, and availability across hospitals and specialty clinics. These devices are designed to occupy space within the stomach and promote satiety while supporting structured weight-management programs.

Their established treatment protocols and growing physician familiarity have contributed to the segment's strong market position. Improvements in balloon materials, filling mechanisms, valve designs, and durability are also supporting product development.

Single balloons can be filled with saline or gas depending on the specific system. The choice of filling material can influence balloon characteristics, patient experience, and treatment requirements.

The increasing prevalence of obesity, expanding bariatric and endoscopic treatment infrastructure, and rising awareness of non-surgical weight-loss options are expected to sustain demand for single-balloon systems throughout the forecast period.

North America Leads the Global Intragastric Balloons Market

North America dominated the global intragastric balloons market in 2025, accounting for approximately 41.2% of total market revenue.

The region's leading position is supported by the high prevalence of obesity, established healthcare infrastructure, specialized bariatric centers, and growing awareness of minimally invasive weight-management procedures.

The United States represents a particularly important market because of its large population of patients affected by obesity and obesity-related chronic conditions. Increasing adoption of endoscopic obesity interventions is expanding treatment options beyond traditional bariatric surgery.

The presence of major medical device manufacturers and specialized gastroenterology practices also supports regional development. Healthcare providers are increasingly integrating weight-loss devices into broader obesity-management programs involving nutrition, behavioral modification, and ongoing clinical monitoring.

Europe is another significant market, supported by increasing awareness of obesity treatment and the development of specialized endoscopic services. Asia Pacific is expected to offer substantial growth opportunities as obesity prevalence increases, healthcare infrastructure improves, and medical tourism expands.

Competitive Landscape

The global intragastric balloons market includes medical device manufacturers, obesity-treatment providers, and specialized gastrointestinal healthcare companies.

Major participants include Boston Scientific Corporation, Apollo Endosurgery, Medtimo, Inc., Spatz FGIA Inc., GI Alliance, Medispar NV, Helioscopie, Laboratoire Endalis, Silimed, MICRO-TECH (Nanjing) Co., Ltd., Bariatric Solutions GmbH, and OxiGênios.

Companies are focusing on improving balloon design, treatment convenience, patient safety, adjustability, and clinical outcomes. Product innovation is increasingly centered on reducing procedural requirements and improving the patient experience.

Strategic partnerships between device manufacturers and healthcare providers are also helping expand access to intragastric balloon therapy. Companies are investing in clinical evidence, regulatory approvals, physician education, and commercialization programs to strengthen their positions.

The competitive environment is expected to become increasingly technology-driven as manufacturers develop swallowable, adjustable, and digitally supported treatment systems.

Key Market Developments

In February 2026, Allurion Technologies announced that the U.S. Food and Drug Administration approved the premarket approval application for the Allurion Gastric Balloon System, featuring the Allurion Smart Capsule. The system is designed to be swallowed during an office visit and filled after reaching the stomach, providing a non-surgical approach to temporary gastric balloon therapy.

In April 2024, Opus Diagnostics and Gastric Balloon Group announced the launch of an advanced weight-loss solution in Ascot and Berkshire in the U.K. The initiative combined intragastric balloon treatment with nutritional counseling and clinical support to expand access to minimally invasive obesity-management services.

In February 2024, Spatz Medical announced the commercialization of the Spatz3 Adjustable Gastric Balloon in the United States. The company highlighted the system's adjustable design and global patient experience as part of its expansion into the U.S. market.

Future Outlook

The future of the global intragastric balloons market remains promising as obesity prevalence continues to increase and patients seek alternatives to more invasive bariatric procedures.

The market is projected to grow from USD 86.8 million in 2025 to USD 364.6 million by 2036, representing a strong 13.9% CAGR from 2026 to 2036.

Technological advances in swallowable and adjustable balloon systems are expected to improve treatment accessibility, personalization, and patient experience. At the same time, growing integration of balloon therapy with nutrition programs, behavioral counseling, digital health platforms, and long-term weight-management services could strengthen clinical adoption.

North America is expected to remain a leading regional market, while Europe, Asia Pacific, Latin America, and the Middle East & Africa offer additional opportunities as healthcare infrastructure and awareness of minimally invasive obesity treatments improve.

Overall, the combination of rising obesity prevalence, growing preference for non-surgical interventions, medical tourism, technological innovation, and expanding specialized obesity-care infrastructure is expected to support sustained growth of the global intragastric balloons industry through 2036.

Buy Full Report Now: https://www.transparencymarketresearch.com/checkout.php?rep_id=26006<ype=S

→Explore Latest Research Reports by Transparency Market Research:

Ostomy Dressing Market

Asthma Spacers Market

Gynecological Devices Market

Ultrasound Devices Market

Neurosurgery Market

About Transparency Market Research

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Media Contact: 

Abhishek Budholiya

Transparency Market Research Inc.

State Tower, 90 State Street, Suite 700,

Albany NY - 12207, United States

Tel: +1-518-618-1030

USA – Canada Toll Free: 866-552-3453

Website: https://www.transparencymarketresearch.com 

Sales Inquiries: sales@transparencymarketresearch.com

Media Inquiries: media@transparencymarketresearch.com